Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d’Ivoire, malaria remains a high priority and accounts for the majority of consultations...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Tropical Medicine and Infectious Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2414-6366/10/1/10 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587448373215232 |
|---|---|
| author | Orphée Kangah Issaka Zongo Alassane Haro William Yavo |
| author_facet | Orphée Kangah Issaka Zongo Alassane Haro William Yavo |
| author_sort | Orphée Kangah |
| collection | DOAJ |
| description | Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d’Ivoire, malaria remains a high priority and accounts for the majority of consultations and deaths in children under five. The recent revision of the criteria for the introduction of seasonal malaria chemoprevention has made the north of Côte d’Ivoire, where malaria transmission is seasonal, eligible for the SMC. We conducted a pilot study in this part of the country to assess the acceptability and feasibility of five cycles of SMC in 1701 children. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine + amodiaquine (SP + AQ) was administered monthly to eligible children over five months. A qualitative approach and quantitative surveys were used to assess the strategy acceptability and feasibility in the study area. Overall, there was a positive perception, attitude, and adherence towards the seasonal malaria chemoprevention in this study area. |
| format | Article |
| id | doaj-art-ab44c423fdf5463c9350d9c3b4603922 |
| institution | Kabale University |
| issn | 2414-6366 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Tropical Medicine and Infectious Disease |
| spelling | doaj-art-ab44c423fdf5463c9350d9c3b46039222025-01-24T13:51:22ZengMDPI AGTropical Medicine and Infectious Disease2414-63662024-12-011011010.3390/tropicalmed10010010Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’IvoireOrphée Kangah0Issaka Zongo1Alassane Haro2William Yavo3National Institute of Public Health, Abidjan BP V 47, Côte d’IvoireInstitut de Recherche en Sciences de la Santé—Direction Régionale de l’Ouest (IRSS-DRO), Bobo-Dioulasso BP 2779, Burkina FasoInstitut de Recherche en Sciences de la Santé—Direction Régionale de l’Ouest (IRSS-DRO), Bobo-Dioulasso BP 2779, Burkina FasoNational Institute of Public Health, Abidjan BP V 47, Côte d’IvoireSeasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d’Ivoire, malaria remains a high priority and accounts for the majority of consultations and deaths in children under five. The recent revision of the criteria for the introduction of seasonal malaria chemoprevention has made the north of Côte d’Ivoire, where malaria transmission is seasonal, eligible for the SMC. We conducted a pilot study in this part of the country to assess the acceptability and feasibility of five cycles of SMC in 1701 children. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine + amodiaquine (SP + AQ) was administered monthly to eligible children over five months. A qualitative approach and quantitative surveys were used to assess the strategy acceptability and feasibility in the study area. Overall, there was a positive perception, attitude, and adherence towards the seasonal malaria chemoprevention in this study area.https://www.mdpi.com/2414-6366/10/1/10seasonal malaria chemopreventionacceptabilityfeasibilitynorth Côte d’Ivoire |
| spellingShingle | Orphée Kangah Issaka Zongo Alassane Haro William Yavo Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire Tropical Medicine and Infectious Disease seasonal malaria chemoprevention acceptability feasibility north Côte d’Ivoire |
| title | Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire |
| title_full | Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire |
| title_fullStr | Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire |
| title_full_unstemmed | Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire |
| title_short | Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire |
| title_sort | assessing the acceptability and feasibility of five cycles of seasonal malaria chemoprevention in cote d ivoire |
| topic | seasonal malaria chemoprevention acceptability feasibility north Côte d’Ivoire |
| url | https://www.mdpi.com/2414-6366/10/1/10 |
| work_keys_str_mv | AT orpheekangah assessingtheacceptabilityandfeasibilityoffivecyclesofseasonalmalariachemopreventionincotedivoire AT issakazongo assessingtheacceptabilityandfeasibilityoffivecyclesofseasonalmalariachemopreventionincotedivoire AT alassaneharo assessingtheacceptabilityandfeasibilityoffivecyclesofseasonalmalariachemopreventionincotedivoire AT williamyavo assessingtheacceptabilityandfeasibilityoffivecyclesofseasonalmalariachemopreventionincotedivoire |